United Therapeutics Corporation (UTHR)
USD 357.55
(-5.83%)
USD 357.55
(-5.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 978 Million | 802.5 Million | 598.2 Million | 755.7 Million | -206.6 Million | 778.4 Million |
| Net Income | 984.8 Million | 727.3 Million | 475.8 Million | 514.79 Million | -104.5 Million | 589.2 Million |
| Depreciation & Amortization | 53.2 Million | 51.3 Million | 49.9 Million | 49.9 Million | 45.9 Million | 35.9 Million |
| Deferred income taxes | 3.6 Million | -71.7 Million | -89.7 Million | -168.1 Million | -82.7 Million | -104.3 Million |
| Stock-based compensation | 39.1 Million | 106.8 Million | 138.5 Million | 163.8 Million | 45.4 Million | -26.4 Million |
| Change in working capital | -97.8 Million | -35.1 Million | -48.8 Million | 4.3 Million | 37.3 Million | 130.7 Million |
| Other non-cash items | -4.9 Million | 23.9 Million | 72.5 Million | 191 Million | -148 Million | 153.3 Million |
| Investing Cash Flow | -719.6 Million | -811.5 Million | -486.9 Million | -738.5 Million | -335.4 Million | -820.6 Million |
| Investments in PPE | -230.4 Million | -138.8 Million | -120.8 Million | -59.3 Million | -83.7 Million | -184.4 Million |
| Acquisitions | -89.2 Million | 7.1 Million | 366.1 Million | 681.6 Million | -20.5 Million | -124.1 Million |
| Investment purchases | -2.51 Billion | -1.7 Billion | -1.89 Billion | -2.3 Billion | -1.27 Billion | -867 Million |
| Sales/Maturities of investments | 2.13 Billion | 1.02 Billion | 1.52 Billion | 1.62 Billion | 1.04 Billion | 400.9 Million |
| Other Investing Activities | -23 Million | 3.5 Million | -366.1 Million | -679.2 Million | 8 Million | -636.2 Million |
| Financing Cash Flow | -11.9 Million | 75.4 Million | 44.8 Million | -16.9 Million | 611.2 Million | 6.3 Million |
| Debt repayment | -100 Million | -800 Million | - | -50 Million | -200 Million | -250 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -13.8 Million | -11.4 Million | -10.8 Million | -3.7 Million | -2.1 Million | - |
| Common Stock Issuance | 6.6 Million | 94.3 Million | 55.6 Million | 38.5 Million | 14 Million | 19.5 Million |
| Other Financing Activities | 193.3 Million | 86.8 Million | -10.8 Million | 36.8 Million | 813.3 Million | 256.3 Million |
| Accounts receivables | -58.5 Million | -21.7 Million | -41.3 Million | -6 Million | 24.4 Million | 121.4 Million |
| Accounts payables | 57.1 Million | 150.6 Million | 112.9 Million | -16.8 Million | -16.3 Million | -11 Million |
| Inventory | -13.6 Million | -13.4 Million | -7.5 Million | 10.3 Million | 12.9 Million | 9.3 Million |
| Other working capital | -82.8 Million | -150.6 Million | -112.9 Million | 16.8 Million | 16.3 Million | 4.7 Million |
| Cash at beginning of period | 961.2 Million | 894.8 Million | 738.7 Million | 738.4 Million | 669.2 Million | 705.1 Million |
| Cash at end of period | 1.2 Billion | 961.2 Million | 894.8 Million | 738.7 Million | 738.4 Million | 669.2 Million |
| Capital Expenditure | -230.4 Million | -138.8 Million | -120.8 Million | -59.3 Million | -83.7 Million | -184.4 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 246.5 Million | 66.4 Million | 156.1 Million | 300 Thousand | 69.2 Million | -35.9 Million |
| Free Cash Flow | 747.6 Million | 663.7 Million | 477.4 Million | 696.4 Million | -290.3 Million | 594 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 309.1 Million | 278.1 Million | 306.6 Million | 217.1 Million | 984.8 Million | 267.6 Million |
| Depreciation & Amortization | 19.1 Million | 18.7 Million | 15 Million | 13.7 Million | 53.2 Million | 13.3 Million |
| Deferred income taxes | 3.5 Million | -3.5 Million | - | 76.7 Million | 3.6 Million | -2.5 Million |
| Stock-based compensation | 41.7 Million | 49.7 Million | 25.6 Million | 16.6 Million | 39.1 Million | 21.1 Million |
| Change in working capital | 13 Million | -108.8 Million | 39.8 Million | -91.7 Million | -97.8 Million | 10.9 Million |
| Other non-cash items | -5.7 Million | 54 Million | -10.5 Million | -5 Million | -4.9 Million | 35.8 Million |
| Investing Cash Flow | -114.9 Million | -80 Million | 735.3 Million | 42.1 Million | -719.6 Million | -313.4 Million |
| Investments in PPE | -76.5 Million | -45.1 Million | -38.2 Million | -78.7 Million | -230.4 Million | -65.7 Million |
| Acquisitions | - | - | - | -89.2 Million | -89.2 Million | 237.1 Million |
| Investment purchases | -407.8 Million | -231 Million | -529.3 Million | -308 Million | -2.51 Billion | -644.8 Million |
| Sales/Maturities of investments | 387.2 Million | 196.5 Million | 1.3 Billion | 526.7 Million | 2.13 Billion | 407.7 Million |
| Other Investing Activities | -17.8 Million | -400 Thousand | -4.3 Million | -8.7 Million | -23 Million | -247.7 Million |
| Financing Cash Flow | -64.1 Million | -48 Million | -1.06 Billion | -92.8 Million | -11.9 Million | 7.6 Million |
| Debt repayment | -100 Million | -100 Million | -100 Million | -100 Million | -100 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -400 Thousand | -11.5 Million | -1 Billion | -100 Thousand | -13.8 Million | -200 Thousand |
| Common Stock Issuance | -48.3 Million | 52.1 Million | 3.9 Million | 7.3 Million | 6.6 Million | 7.8 Million |
| Other Financing Activities | 36.3 Million | -100 Thousand | -14.1 Million | 7.3 Million | 193.3 Million | -200 Thousand |
| Accounts receivables | -51.1 Million | 16.5 Million | -28.3 Million | -20.3 Million | -58.5 Million | 14 Million |
| Accounts payables | 33 Million | 25.8 Million | 1.9 Million | -23.1 Million | 57.1 Million | 4.3 Million |
| Inventory | -11.3 Million | -14.7 Million | -9.3 Million | -7 Million | -13.6 Million | -3.1 Million |
| Other working capital | 75.4 Million | -136.4 Million | 75.5 Million | -41.3 Million | -82.8 Million | -4.3 Million |
| Cash at beginning of period | 1.35 Billion | 1.25 Billion | 1.2 Billion | 1.1 Billion | 961.2 Million | 1.06 Billion |
| Cash at end of period | 1.55 Billion | 1.35 Billion | 1.25 Billion | 1.2 Billion | 1.2 Billion | 1.1 Billion |
| Capital Expenditure | -76.5 Million | -45.1 Million | -38.2 Million | -78.7 Million | -230.4 Million | -65.7 Million |
| Effect of forex changes on cash | - | - | - | -106.6 Million | - | - |
| Net cash flow / Change in cash | 198.2 Million | 104.2 Million | 43.8 Million | 100 Million | 246.5 Million | 40.4 Million |
| Free Cash Flow | 300.7 Million | 187.1 Million | 338.3 Million | 72 Million | 747.6 Million | 280.5 Million |
EDTK
WESTLIFE
USDR
6185
SRU-UN
PYRAMID